help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 22, 2008
Molecular Endocrinology, doi:10.1210/me.2008-0015
Molecular Endocrinology Vol. 0, No. 2008 200800151-
doi:10.1210/me.2008-0015
Copyright © 2008 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/8/1825    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, H.
Right arrow Articles by Carter-Su, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, H.
Right arrow Articles by Carter-Su, C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH

Submitted on January 11, 2008
Accepted on May 15, 2008

JAK2, but Not Src Family Kinases, is Required for STAT, ERK and Akt Signaling in Response to Growth Hormone in Preadipocytes and Hepatoma Cells

Hui Jin, Nathan J. Lanning, and Christin Carter-Su*

Department of Molecular and Integrative Physiology (H.J., C.C.-S.), Graduate Program in Cellular and Molecular Biology (N.J.L., C. C.-S.), University of Michigan Medical School, Ann Arbor, MI 48109-5622

* To whom correspondence should be addressed. E-mail: cartersu{at}umich.edu.

Janus kinase 2 (JAK2), a tyrosine kinase that associates with the growth hormone (GH) receptor and is activated by GH, has been implicated as a key mediator of GH signaling. Several published reports suggest that members of the Src family of tyrosine kinases may also participate in GH signaling. We therefore investigated the extent to which JAK2 and Src family kinases mediate GH activation of STATs 1, 3, and 5a/b, ERKs 1 and 2, and Akt, in the highly GH-responsive cell lines 3T3-F442A preadipocytes and H4IIE hepatoma cells. GH activation of Src family kinases was not detected in either cell line. Further, blocking basal activity of Src kinases with the Src inhibitors PP1 and PP2 did not inhibit GH activation of STATs 1, 3 or 5a/b, or ERKs 1 and 2. When levels of JAK2 were depressed by shRNA in 3T3-F442A and H4IIE cells, GH-stimulated activation of STATs 1, 3 and 5a/b, ERKs 1 and 2, and Akt were significantly reduced, however, basal activity of Src family kinases was unaffected. These results were supported genetically by experiments showing that GH robustly activates JAK2, STATs 3 and 5a/b, ERKs 1 and 2, and Akt in murine embryonic fibroblasts derived from Src/Yes/ Fyn (SYF) triple knock out embryos that lack known Src kinases. These results strongly suggest that JAK2, but not Src family kinases, is critical for transducing these GH signals in 3T3-F442A and H4IIE cells.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society